Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.
about
Bioengineering solutions for manufacturing challenges in CAR T cells.The Promise and Challenge of In Vivo Delivery for Genome Therapeutics.Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf.Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells.T-cell Immunotherapies and the Role of Nonclinical Assessment: The Balance between Efficacy and Pathology.Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T CellsBlossom of CRISPR technologies and applications in disease treatment
P2860
Q38637370-E49D367D-9F52-4557-BEEF-6B0186D13ED8Q41919375-1ED715E5-0DF3-462B-83E7-5ED06CE48A01Q47215994-767DD154-F7DB-45C5-B057-AF232D8FFB24Q50024744-ECF2BE2E-63B1-4F7F-BD49-73A9FCF9B79EQ52689465-C11C2374-8CC2-4A68-871C-7E2A6CA47AD3Q57173949-DB95E955-A03E-4304-A8C6-5054DBD7DFEAQ58120494-3EF2A179-CB22-40D3-96EC-8C37C01550E2
P2860
Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.
@en
type
label
Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.
@en
prefLabel
Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.
@en
P2860
P921
P1433
P1476
Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
@en
P2093
Jiangtao Ren
P2860
P2888
P304
P356
10.1007/S13238-017-0410-X
P577
2017-04-22T00:00:00Z
P6179
1085048177